Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Second generation photodynamic agents: a review.

E D Sternberg1, D Dolphin

  • 1Department of Chemistry, University of British Columbia, Vancouver.

Journal of Clinical Laser Medicine & Surgery
|October 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Malaria transmission potential could be reduced with current and future climate change.

Scientific reports·2016
Same author

The synthesis and properties of new 2-pyrrolylthiones as chelating agents for transition metals and technetium.

Bioorganic & medicinal chemistry letters·2001
Same author

Synthesis, structure and properties of 1,19-disubstituted tetradehydrocorrin cobalt complexes.

Journal of inorganic biochemistry·2001
Same author

2-pyrrolylthiones as monoanionic bidentate N,S-chelators: synthesis and molecular structure of 2-pyrrolylthionato complexes of nickel(II), cobalt(III), and mercury(II).

Inorganic chemistry·2001
Same author

Magnetic resonance imaging evaluation of photodynamic therapy-induced hemorrhagic necrosis in the murine M1 tumor model.

Photochemistry and photobiology·1998
Same author

Application of long-circulating liposomes to cancer photodynamic therapy.

Biological & pharmaceutical bulletin·1997
Same journal

Laser literature watch.

Journal of clinical laser medicine & surgery·2004
Same journal

Photobiological basis and clinical role of low-intensity lasers in biology and medicine.

Journal of clinical laser medicine & surgery·2004
Same journal

Comparative study of dentine permeability after apicectomy and surface treatment with 9.6 microm TEA CO2 and Er:YAG laser irradiation.

Journal of clinical laser medicine & surgery·2004
Same journal

Low-level laser treatment can reduce edema in second degree ankle sprains.

Journal of clinical laser medicine & surgery·2004
Same journal

Morpho-structural aspects of Er:YAG-prepared class V cavities.

Journal of clinical laser medicine & surgery·2004
Same journal

Effect of low-intensity (3.75-25 J/cm2) near-infrared (810 nm) laser radiation on red blood cell ATPase activities and membrane structure.

Journal of clinical laser medicine & surgery·2004
See all related articles

Photodynamic therapy uses lasers and photosensitizing dyes to treat cancer. Newer, second-generation dyes are in clinical trials, showing promise for improved cancer treatment outcomes.

Area of Science:

  • Oncology
  • Biomedical Engineering
  • Photochemistry

Background:

  • Laser treatment for neoplastic diseases is increasingly common.
  • Photosensitizing dyes enhance the efficacy of light-induced cancer therapies.
  • Photofrin, a first-generation agent, is approved for bladder cancer treatment in Canada.

Purpose of the Study:

  • To review the status of ongoing clinical trials for second-generation photosensitizing dyes.
  • To discuss the mechanistic aspects of photodynamic therapy (PDT).
  • To evaluate the future potential of various laser instruments for PDT applications.

Main Methods:

  • Review of phase I/II clinical trials for novel photosensitizing agents.
  • Analysis of mechanistic principles underlying photodynamic therapy.

Related Experiment Videos

  • Assessment of current and emerging laser technologies for therapeutic use.

    • Main Results:

    • Several second-generation photosensitizing dyes are currently in phase I/II clinical trials.
    • These newer agents are being developed to offer improved properties over first-generation dyes.
    • The review provides insights into the potential future applications of specific laser systems in PDT.

    Conclusions:

    • Second-generation photosensitizing dyes represent a significant advancement in photodynamic therapy.
    • Ongoing clinical trials are crucial for validating the efficacy and safety of these new agents.
    • The selection of appropriate laser technology will be key to optimizing future photodynamic cancer treatments.